Number of predicted peptides that could bind to HLA-A, HLA-B, and HLA-C according to BIMAS
. | No. of peptides . | . | . | ||
|---|---|---|---|---|---|
| Patient no. . | HLA-A . | HLA-B . | HLA-C . | ||
| 1 | 4 (A1)† | 12 (B62 = B15) | ND | ||
| 9 (A*0201) | 5 (B*4403) | ||||
| 2 | 2 (A1) | 12 (B*4403) | 13 (Cw*0702) | ||
| 2 (B8) | |||||
| 3 | 7 (A*0201) | 12 (B7) | 14 (Cw*0702) | ||
| 15 (A24) | 11 (B62 = B15) | ||||
| 4 | 4 (A*0201) | 3 (B7) | 16 (Cw*0401) | ||
| 2 (A*1101) | 12 (B*3501) | 26 (Cw*0602) | |||
| 5 | 7 (A3) | 12 (B7) | 18 (Cw*0301) | ||
| 9 (B40) | 18 (Cw*0702) | ||||
| Total | 50 | 90 | 105 | ||
. | No. of peptides . | . | . | ||
|---|---|---|---|---|---|
| Patient no. . | HLA-A . | HLA-B . | HLA-C . | ||
| 1 | 4 (A1)† | 12 (B62 = B15) | ND | ||
| 9 (A*0201) | 5 (B*4403) | ||||
| 2 | 2 (A1) | 12 (B*4403) | 13 (Cw*0702) | ||
| 2 (B8) | |||||
| 3 | 7 (A*0201) | 12 (B7) | 14 (Cw*0702) | ||
| 15 (A24) | 11 (B62 = B15) | ||||
| 4 | 4 (A*0201) | 3 (B7) | 16 (Cw*0401) | ||
| 2 (A*1101) | 12 (B*3501) | 26 (Cw*0602) | |||
| 5 | 7 (A3) | 12 (B7) | 18 (Cw*0301) | ||
| 9 (B40) | 18 (Cw*0702) | ||||
| Total | 50 | 90 | 105 | ||
Predicted peptides are defined as a predicted binding half-life of at least 1 minute.12,19
HLA types are indicated in parentheses.
ND indicates not determined.
HLA-ABC subtypes.